{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:06:12Z","timestamp":1791029172584,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":6423,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1111\/j.1600-6143.2005.00852.x","type":"journal-article","created":{"date-parts":[[2005,4,5]],"date-time":"2005-04-05T06:30:22Z","timestamp":1112682622000},"page":"1120-1129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":133,"title":["Renal Histopathological Lesions After Orthotopic Liver Transplantation (OLT)"],"prefix":"10.1016","volume":"5","author":[{"given":"Evangeline","family":"Pillebout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Nochy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Antoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvon","family":"Calmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Glotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2005.00852.x_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00007890-199407270-00007","article-title":"Nephrotoxicity following orthotopic liver transplantation. A comparison between cy-closporine and FK506.","volume":"58","author":"Platz","year":"1994","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00007890-199502150-00010","article-title":"Impact of pretransplant renal function on survival after liver transplantation.","volume":"59","author":"Gonwa","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00007890-200002150-00013","article-title":"Late-onset renal failure after liver transplantation: role of posttransplant alcohol use.","volume":"69","author":"Gayowski","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ.","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-2007-1007201","article-title":"Hepatorenal syndrome.","volume":"17","author":"Bataller","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib6","first-page":"563","article-title":"Hepatorenal syndrome: emerging perspectives.","volume":"17","author":"Epstein","year":"1997","journal-title":"Semin Nephrol"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1053\/j.ajkd.2003.08.017","article-title":"Prediction of GFR in liver transplant candidates.","volume":"42","author":"Skluzacek","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib8","first-page":"1262","article-title":"Combined liver and kidney transplantation in nephropathy associated with liver disease.","volume":"27","author":"Hiesse","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00007890-198803000-00015","article-title":"An analysis of cyclosporine efficacy and toxicity after liver transplantation.","volume":"45","author":"O'Grady","year":"1988","journal-title":"Transplantation"},{"issue":"1 Suppl. 1","key":"10.1111\/j.1600-6143.2005.00852.x_bib10","first-page":"498","article-title":"Experience in 1000 liver transplants under cyclosporine-steroid therapy: a survival report.","volume":"20","author":"Iwatsuki","year":"1988","journal-title":"Transplant Proc"},{"issue":"Suppl. 1","key":"10.1111\/j.1600-6143.2005.00852.x_bib11","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1111\/j.1432-2277.1994.tb01310.x","article-title":"Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients.","volume":"7","author":"Platz","year":"1994","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","article-title":"Cyclosporine-associated chronic nephropathy.","volume":"311","author":"Myers","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib13","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00007890-198811000-00014","article-title":"Chronic injury of human renal microvessels with low-dose cyclosporine therapy.","volume":"46","author":"Myers","year":"1988","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ki.1996.415","article-title":"Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy.","volume":"50","author":"Bennett","year":"1996","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib15","first-page":"17","article-title":"Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations.","volume":"17","author":"Andoh","year":"1997","journal-title":"Semin Nephrol"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/ajkd.1998.v32.pm9708608","article-title":"Cyclosporine arteriolopathy: effects of drug withdrawal.","volume":"32","author":"Franceschini","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005792-200207000-00008","article-title":"Alpha-interferon-associated thrombotic microangiopathy: a clinicopathologic study of 8 patients and review of the literature.","volume":"81","author":"Zuber","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib18","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/ndt\/16.4.846","article-title":"Renal thrombotic microangiopathy induced by interferon-alpha.","volume":"16","author":"Badid","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2893.1999.00148.x","article-title":"Long-term administration of interferon-alpha in non-responder patients with chronic hepatitis C: follow-up of liver fibrosis over 5 years.","volume":"6","author":"Guerret","year":"1999","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s005350050139","article-title":"Thrombotic thrombocytopenic purpura developed suddenly during interferon treatment for chronic hepatitis C.","volume":"33","author":"Iyoda","year":"1998","journal-title":"J Gastroenterol"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000045147","article-title":"Hemolytic uremic syndrome associated with beta-interferon therapy for chronic hepatitis C.","volume":"80","author":"Ubara","year":"1998","journal-title":"Nephron"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib22","unstructured":"Naunyn B. Der Diabete Mellitus. Wien, Austria: Holder, 1898: 38."},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib23","first-page":"A3805","article-title":"Diabetic nephropathy\u2014a frequent complication of liver transplant?","volume":"11","author":"Nochy","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology.","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00041552-199307000-00017","article-title":"The nephrotoxicity of FK506 as compared with cyclosporine.","volume":"2","author":"McCauley","year":"1993","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0140-6736(93)92345-T","article-title":"Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation.","volume":"342","author":"Legendre","year":"1993","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","article-title":"The intrarenal vascular lesions associated with primary antiphospholipid syndrome.","volume":"10","author":"Nochy","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","article-title":"Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future.","volume":"35","author":"de Mattos","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1681\/ASN.V42129","article-title":"The kidney in liver transplantation.","volume":"4","author":"Distant","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib30","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1523-1755.1998.00004.x","article-title":"Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation.","volume":"54","author":"Fraley","year":"1998","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00007890-199807150-00010","article-title":"Chronic renal failure following liver transplantation: a retrospective analysis.","volume":"66","author":"Fisher","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","article-title":"De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.","volume":"41","author":"Schwimmer","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib33","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0168-8278(02)00302-1","article-title":"Cutaneous thrombotic microangiopathy during treatment with alphainterferon for chronic hepatitis C.","volume":"37","author":"Creput","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib34","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(67)90334-0","article-title":"Glucose tolerance and diabetes in chronic liver disease.","volume":"2","author":"Megyesi","year":"1967","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0168-8227(94)90157-0","article-title":"Diabetes mellitus in patients with liver cirrhosis.","volume":"25","author":"Vidal","year":"1994","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib36","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0168-8278(88)80015-1","article-title":"Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.","volume":"28","author":"Kruszynska","year":"1998","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/hep.1840180210","article-title":"Glucose resistance contributes to diabetes mellitus in cirrhosis.","volume":"18","author":"Petrides","year":"1993","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib38","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hep.510310320","article-title":"Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation.","volume":"31","author":"Perseghin","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib39","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/hep.510300416","article-title":"Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection.","volume":"30","author":"Caronia","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib40","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1053\/jhep.2001.0103306le01","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.","volume":"33","author":"Mehta","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00007890-199708150-00012","article-title":"Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.","volume":"64","author":"Mayer","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib42","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/bmj.318.7191.1104","article-title":"Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials.","volume":"318","author":"Knoll","year":"1999","journal-title":"Br Med J"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/lt.500050209","article-title":"Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events.","volume":"5","author":"Jain","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib44","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0140-6736(96)07588-5","article-title":"Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.","volume":"348","author":"Cittanova","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib45","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(00)04211-2","article-title":"Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a mul-ticentre randomised study.","volume":"357","author":"Schortgen","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib46","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977\u2013986.","DOI":"10.1056\/NEJM199309303291401"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib47","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 1995; 47: 1703\u20131720.","DOI":"10.1038\/ki.1995.236"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/bmj.306.6871.175","article-title":"Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes.","volume":"306","author":"Hallab","year":"1993","journal-title":"Br Med J"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib49","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.The Collaborative Study Group.","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib50","doi-asserted-by":"crossref","unstructured":"UKPDS 38. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. Be Med J 1998; 317: 703\u2013713.","DOI":"10.1136\/bmj.317.7160.703"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib51","doi-asserted-by":"crossref","unstructured":"UKPDS 39. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. Br Med J 1998; 317: 713\u2013720.","DOI":"10.1136\/bmj.317.7160.713"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib52","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","article-title":"Blood pressure control, proteinuria, and the progression of renal disease. The Modifica-tion of Diet in Renal Disease Study.","volume":"123","author":"Peterson","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2005.00852.x_bib53","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/01.HYP.29.2.641","article-title":"Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group.","volume":"29","author":"Lazarus","year":"1997","journal-title":"Hypertension"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2005.00852.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522036838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522036838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2005.00852.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:34:42Z","timestamp":1761626082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522036838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S1600613522036838"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2005.00852.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal Histopathological Lesions After Orthotopic Liver Transplantation (OLT)","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2005.00852.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}